About Kanvas Biosciences
Kanvas Biosciences is a private company based in Monmouth Junction, New Jersey, incorporated in 2020 in Delaware. It has reported $15,689,994 raised in two offerings on Form D since June 2023. Its chief executive is Matthew Cheng.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 4, 2024 | Mar 18, 2024 | $3,914,994of $10.0M target | 54 | $72,500 | EquityRule 506(b) | Form D ↗ |
| Jun 1, 2023 | Jun 13, 2023 | $11,775,000of $12.0M target | 12 | $981K | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, two offerings | $15,689,994 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Kanvas Biosciences's Form D filed Mar 18, 2024.
Earlier filings also listed Justin Smithline (director, last listed Jun 2023) and Iwijn De Vlaminck (executive officer and director, last listed Jun 2023).